About the Company
applied therapeutics, inc. is a hospital and health care company located in 3104 cherry palm dr, tampa, fl, united states.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Employees
31
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $APLT News
Applied Therapeutics (APLT) Surges 124% in a Month: Here's Why
Applied Therapeutics, Inc. APLT, a clinical-stage company, is currently focused on developing novel therapies against rare ...
Applied Therapeutics Inc (APLT) Announces Year-End 2023 Financial Results and Clinical Progress
Financing: Completed a $100 million Private Placement, extending cash runway into 2026.
Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
NDA for govorestat accepted and granted Priority Review by FDA for the treatment of Classic Galactosemia; PDUFA target action date of August 28, ...
Applied Therapeutics Rallies After Announcing Private Placement Of Shares
(RTTNews) - Shares of Applied Therapeutics, Inc. (APLT) are surging more than 40 percent Wednesday morning after the clinical-stage biopharmaceutical company announced a private placement to the tune ...
Analysts Offer Insights on Healthcare Companies: Applied Therapeutics (APLT), Xeris Pharmaceuticals (XERS) and Arcturus Therapeutics (ARCT)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Applied Therapeutics (APLT – Research ...
Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation ...
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2023 Earnings Call Transcript
March 7, 2024 Arcturus Therapeutics Holdings Inc. beats earnings expectations. Reported EPS is $-0.32, expectations were ...
Allogene Therapeutics, Inc.: Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
March 14, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology ... ALLO-329: CD19 Dagger ® in Autoimmune Disease (AID) The Company has applied its deep ...
Applied DNA Sciences, Inc.: Applied DNA to Showcase Linea DNA and Linea IVT Platforms at 24th Annual World Vaccine Congress
STONY BROOK, NY / ACCESSWIRE / March 14, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, will showcase its Linea IVT and Linea DNA platforms at t ...
Q4 2023 Allogene Therapeutics Inc Earnings Call
Christine Cassiano; EVP, Chief Corporate Affairs and Brand Strategy Officer; Allogene Therapeutics Inc David Chang ... are relative nadir is a very interesting proposition and can be applied to other ...
Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress
STONY BROOK, NY / ACCESSWIRE / March 14, 2024 / Applied DNA Sciences ... DNA for use in the production of nucleic acid-based therapeutics and, through our recent acquisition of Spindle Biotech, Inc. ( ...
Q4 2023 Arcturus Therapeutics Holdings Inc Earnings Call
Neda Safarzadeh; VP of IR, Public Relations, and Marketing; Arcturus Therapeutics Holdings, Inc. Joe Payne; President and CEO ... Our validated vaccine platform is now being applied to seven global ...
Loading the latest forecasts...